In this webinar we discuss our 3D disease models and their use in drug development emphasizing the capacity of our patient-derived platform to mimic the native architecture of human tissues in an organ- and disease-specific manner and its high correlation with clinical response.

Predictive Oncology
Molecule to Market podcast: Dr. Pamela Bush
“Pamela’s unwavering passion for a cancer cure paved the way for an incredible opportunity to directly make a difference in the lives of countless people,”